However, other NCs are usually modified with targeting ligands to specifically bind to overexpressed receptors, such as folate receptor, integrin, human epidermal growth factor receptor 2, and TfR1, on the surface of tumor cells.44 This evidence concerns the gene ERBB2 and neoplasm.